Latest filing published 21 Apr 2026 for Nuvation Bio Inc., €91k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +192.4%Entry US$1.97 · Close at T+365 US$5.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kerry Wentworth: trading record in brief
Filings by Kerry Wentworth span 3 companies, the busiest being Agenus Inc, Flexion Therapeutics Inc and Nuvation Bio Inc. Between 7 January 2008 and 17 April 2026, the trades on record add up to 80 filings.
In open-market terms, that means 2 purchases worth €78k on one side and 23 sales worth €1.3M on the other. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 41 share grants and 5 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
Most recently, on 21 April 2026, the filings show an option exercise worth €91k in Nuvation Bio Inc. The most recent open-market purchase was published on 18 June 2025, 508 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kerry Wentworth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 36,750 shares@ US$2.930.0053% mcap6.5% of flowClass A Common StockSEC:0001369453-26-000006:0
- 36,750 shares@ US$5.01440.0092% mcap11.2% of flowClass A Common StockSEC:0001369453-26-000006:1
- 100,000 shares@ US$1.9412.0% of flowClass A Common StockSEC:0001369453-26-000005:1
- 200,000 shares@ US$4.517855.9% of flowClass A Common StockSEC:0001369453-26-000005:2
- 100,000 shares@ US$1.8711.6% of flowClass A Common StockSEC:0001369453-26-000005:0
- 24,000 shares@ US$1.802.6% of flowClass A Common StockSEC:0001415889-25-017657:1Canonical exit: 14 Sept 2025 (T+90)
- 26,000 shares@ US$1.792.9% of flowClass A Common StockSEC:0001415889-25-017657:0Canonical exit: 14 Sept 2025 (T+90)
- 6,000 shares@ US$8.503.6% of flowCommon StockSEC:0001209191-21-065709:1
- 140,843 shares@ US$8.5097.7% of flowCommon StockSEC:0001209191-21-065709:0
- 3,944 shares@ US$6.452.0% of flowCommon StockSEC:0001209191-21-047504:0
- 539 shares@ US$7.780.3% of flowCommon StockSEC:0001209191-21-043523:0
- 30,000 shares0Common StockSEC:0001209191-21-017271:0
- 6,829 shares@ US$11.135.0% of flowCommon StockSEC:0001209191-21-002565:0
- 38,750 shares0Common StockSEC:0001209191-20-043107:0
- 369 shares@ US$10.830.3% of flowCommon StockSEC:0001209191-20-038719:0
- 31,000 shares0Common StockSEC:0001209191-20-015140:0
- 3,724 sharesCommon StockSEC:0001209191-20-002283:0
- 3,400 sharesCommon StockSEC:0001209191-19-052756:0
- 1,002 shares@ US$13.981.1% of flowCommon StockSEC:0001209191-19-052756:1
- 389 shares@ US$9.810.3% of flowCommon StockSEC:0001209191-19-038761:0
- 36,000 shares0Common StockSEC:0001209191-19-016930:0
- 3,400 sharesCommon StockSEC:0001209191-19-017155:0
- 622 shares@ US$12.360.6% of flowCommon StockSEC:0001209191-19-002084:0
- 1,002 shares@ US$18.601.4% of flowCommon StockSEC:0001209191-18-054524:0
- 171 shares@ US$21.220.3% of flowCommon StockSEC:0001209191-18-039232:0
25 of 73 declarations
